KNIN:SIXKuehne & Nagel International AG Analysis
Data as of 2026-03-14 - not real-time
CHF 171.35
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Kuehne + Nagel trades around the 20‑day SMA, which sits just under the current price, while the 50‑day SMA remains slightly higher, indicating a narrow neutral range. The 14‑day RSI is in the low‑40s, suggesting limited upside momentum, and the MACD histogram is negative, reinforcing a bearish short‑term bias. Volatility is unusually high at nearly 50% over the past month, yet the beta is low, meaning the stock moves less than the market on a systematic basis. Fundamentally, revenue is down 12% year‑over‑year, margins are thin, and the debt‑to‑equity ratio exceeds 170%, highlighting financial strain. The dividend yield of 3.5% looks attractive, but a payout ratio above 100% raises concerns about sustainability. A discounted cash‑flow model values the company at roughly CHF 25, far below the current price of CHF 171, flagging a severe overvaluation. Analyst consensus is neutral with a “hold” rating, and the median price target sits just a few percent above the market, offering limited upside. Given the increasing volume and support around CHF 165, the stock may find short‑term stability, but the long‑term outlook is clouded by weak growth and high leverage.
Overall, the combination of technical weakness, elevated volatility, and a valuation gap suggests caution. Investors should weigh the attractive dividend against the unsustainable payout and the company’s debt load. The prudent approach is to avoid new long positions and consider reducing exposure unless the price approaches the identified support and the earnings trajectory improves.
Overall, the combination of technical weakness, elevated volatility, and a valuation gap suggests caution. Investors should weigh the attractive dividend against the unsustainable payout and the company’s debt load. The prudent approach is to avoid new long positions and consider reducing exposure unless the price approaches the identified support and the earnings trajectory improves.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- Price near identified support level
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Negative revenue growth and thin margins
- Elevated debt‑to‑equity ratio
- Dividend yield offset by unsustainable payout
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair value far below market price
- Persistent overvaluation
- Weak profitability and high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth-11.90%
Profit Margin3.60%
P/E Ratio23.0
ROE33.78%
ROA6.54%
Debt/Equity178.89
P/B Ratio9.3
Op. Cash FlowCHF1.8B
Free Cash FlowCHF456.5M
Industry P/E29.1
Technical Analysis
TrendNeutral
RSI44.0
SupportCHF 165.60
ResistanceCHF 193.30
MA 20CHF 174.69
MA 50CHF 177.96
MA 200CHF 168.73
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCHF 25.66
Target PriceCHF 175.28
Upside/Downside2.29%
GradeOvervalued
TypeValue
Dividend Yield3.52%
Risk Assessment
Beta0.27
Volatility49.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.